Strategic Investment / Expansion
SRF Approves ₹88 Crore Capex for HFC Capacity Expansion
NSE
srf
BSE
503806
SRF Limited has approved a capital expenditure of ₹88 crore to expand its HFC production capacity beyond 65,000 MTPA. The project is expected to be completed within 8 months and will be funded through a mix of debt and internal accruals.
PRICE-SENSITIVE TRIGGER
Event: Capex Approval for Capacity Expansion
Type: Strategic Investment / Expansion
Impact: Positive
Immediate Effect: Strengthens production capacity and enhances growth visibility in high-value fluorochemicals segment
Key Metrics:
- Capex Approved: ₹88 Crore
- Capacity Post Expansion: >65,000 MTPA
- Project Timeline: 8 months
Highlight:
- Capex supports higher utilization of HFC production allowance and capacity expansion
What Happened ?
SRF Limited announced that its Board has approved a capital expenditure of ₹88 crore for expanding its Hydrofluorocarbon (HFC) production capacity. The expansion aims to increase capacity beyond 65,000 MTPA.
key highlights
Capex Details & Strategic Rationale:
- Expansion focused on HFC production capacity
- Enables full utilization of eligible HFC production allowance
- Linked to HCFC-22 production base (2009–10 reference)
- Project completion expected within 8 months
- Funded through a mix of debt and internal accruals
- Strengthens position in fluorochemicals segment
Note:
- The expansion is aligned with regulatory allowances and aims to maximize production efficiency
Risk Analysis
Key Risks
- Regulatory dependency in HFC production quotas
- Demand volatility in fluorochemicals market
- Execution risks within tight timeline
- Pricing pressure in global markets
Worst Case Scenario
- If demand weakens or regulatory constraints tighten, capacity utilization may fall below expectations
Risk Level: Medium
Company Commentary
- Board approved ₹88 crore capex
- Focus on HFC capacity expansion
- Completion timeline of 8 months
- Funded through debt and internal accruals
Official Exchange Filing: SRF Limited